Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-05-29 14:17:00
Reporting Period:
Filing Date:
Accepted Time:
2012-05-29 14:17:00
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG Pharmaceutical Preparations (2834) 042742593
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380022 Michael Narachi C/o Amag Pharmaceuticals, Inc.
100 Hayden Avenue
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-24 2,000 $13.55 2,000 No 4 P Direct
Common Stock Acquisiton 2012-05-25 5,500 $0.00 7,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
  1. The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.9100-$14.0724. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.